戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 /- 0.4 L), functional residual capacity, and residual volume.
2 r lung assessment at total lung capacity and residual volume.
3  retained inflow, delayed ejection flow, and residual volume.
4 e thus resulting in a marked increase in the residual volume.
5  expiration from near total lung capacity to residual volume.
6 ssess patients with suspected large postvoid residual volumes.
7 ificantly fewer episodes of elevated gastric residual volumes (2% vs. 8% of feeding days; p < .001).
8 derived mean lung capacity decreased 13% and residual volume 20% (p < 0.00001 for each), while mean t
9 ction tests were (%predicted): FEV(1) = 27%; residual volume = 224.6%; diffusion capacity = 26.7%.
10 cond, 33+/-4 percent of the predicted value; residual volume, 259+/-25 percent of the predicted value
11 ent feeding days; P = .05), elevated gastric residual volumes (4.9% vs 2.2% of feeding days; P < .001
12 hange in total lung capacity -16%; change in residual volume -55%) in a pattern that resulted in sign
13                             Changes in FEV1, residual volume, 6-minute-walk distance, St. George's Re
14  +/- 15.20 vs. 7.55 +/- 14.88%; P < 0.0001), residual volume (-66.20 +/- 40.26 vs. -47.06 +/- 39.87%;
15 change in total lung capacity +8%; change in residual volume +66%), reduced DL(CO) (-21%), and elevat
16 6 mL/sec +/- 10 (155% +/- 293); and postvoid residual volume, 70 mL +/- 121 (48% +/- 81) (P < .05 for
17 and clinically significant: DeltaEBV-SoC for residual volume, -700 ml; 6-minute-walk distance, +78.7
18  greater LV mass (7.2 g per 1-SD increase in residual volume; 95% confidence interval, 2.2-12; P=0.00
19 nce interval, -0.52 to 1.38), prostate size, residual volume after voiding, quality of life, or serum
20 erformed maximal inspirations initiated from residual volume against an external load representing 30
21        There was no detectable difference in residual volume among treatment groups, but the diminish
22            The ultrasound measured post void residual volume and average urinary flow were significan
23  changes in lung function, such as increased residual volume and decreased flow; these increases in a
24 on states), initial bladder contents volume, residual volume and first void time.
25 bjects, resulted in significant increases in residual volume and pressure-volume hysteresis, suggesti
26 75% of vital capacity, and the ratio between residual volume and total lung capacity were significant
27 ilated patients with mildly elevated gastric residual volumes and already receiving nasogastric nutri
28             REL+rapa versus REL+veh improved residual volumes and micturition fractions toward sham l
29 aire), change in lung function (FVC, FEV(1), residual volume), and change in COPD Assessment Test sco
30 ow limitation (FEV(1)), lung hyperinflation (residual volume), and gas transfer capacity (Dl(CO)) and
31  pressure, voiding volume, bladder capacity, residual volume, and number of non-voiding contractions,
32 se was also associated with higher TLC, FRC, residual volume, and Va along with lower midexpiratory f
33 ures, such as expanding bladder contents and residual volume, and variable urinary input rate, initia
34 al air trapping in prepubertal girls because residual volumes are not detected on standard spirometri
35 h hypertonic saline and placebo, whereas the residual volume as a proportion of total lung capacity (
36  recoil led to disproportionate decreases in residual volume as compared with total lung capacity (16
37        The Rp positively correlated with the residual volume at both 4:00 P.M. (r = 0.71, p = 0.004)
38 eeks) and include only men with low postvoid residual volumes at baseline, and the results are, there
39           The residual volume proportion and residual volume average KE were increased in patients (
40 were significant differences in accuracy and residual volume between syringes, whereas they showed a
41 eased forced expiratory volume and increased residual volume compared with patients with severe asthm
42 rence between TLC total lung capacity and RV residual volume correlated positively with (3)He signal
43 , prostate volume decreased by 20%, postvoid residual volume decreased by 30 mL, and IIEF score incre
44 increased by 390+/-570 ml (P<0.001), and the residual volume decreased by 439+/-493 ml (P=0.02), as c
45 adders and kidneys; however, the severity of residual volumes does not predict increased susceptibili
46                        Primary outcomes were residual volume, FEV(1), St George's Respiratory Questio
47 , actual volume delivered, patient position, residual volume, flush volume, presence of blue food col
48  78 antibody-positive animals had sufficient residual volume for detection of HEV RNA (viremia) by re
49 w fraction [OF], venous filling index [VFI], residual volume fraction [RVF]) and venous duplex, tread
50 t at four lung volumes (residual volume [ RV residual volume ], functional residual capacity [ FRC fu
51 lume group), in contrast to the high gastric residual volume group (n = 9).
52 idual volume higher than 250 mL (low gastric residual volume group), in contrast to the high gastric
53 patients or between the high and low gastric residual volume groups.
54 bility of ultrasonography to measure gastric residual volume (GRV) in this population.
55 ughly quantified at bedside by large gastric residual volumes (GRVs).
56 cardiovascular function, and hyperinflation (residual volume &gt; 135% predicted).
57 L and residual TV <= 4.6 mL or postoperative residual volume &gt; 4.6 mL.
58 yperinflation (total lung capacity >100% and residual volume &gt;150%), a restricted exercise capacity (
59 severe hyperinflation (defined by a baseline residual volume &gt;175% of predicted) who were eligible fo
60      In fed patients, 13 never had a gastric residual volume higher than 250 mL (low gastric residual
61  and air-trapping in total lung capacity and residual volume images, respectively.
62                                              Residual volume improved (decreased) from baseline by a
63 uspended functional residual capacity and at residual volume in two lung regions (above and below the
64                                         Mean residual volumes in the SCI animals did not correlate wi
65  feeding intolerance-defined as high gastric residual volume-in critically ill patients.
66 o one of the following reasons: high gastric residual volumes, increased abdominal girth, distension,
67 ife (QOL) score, peak urinary flow, postvoid residual volume, International Index Erectile Function (
68 irus (Jc1/GLuc2A) to simulate 2 scenarios of residual volumes: low void volume (2 microL) for 1-mL in
69 nclude tests such as uroflowmetry, post-void residual volume measurement, renal ultrasound, (video-)u
70 ved to be in the supine position only 0.45%, residual volume of >200 mL was found 2.8%, and blue food
71  compared with the control were reduction in residual volume of 0.58 L (95% CI -0.80 to -0.37), incre
72                                              Residual volumes of nutrition in the small bowel were <
73 ution was not associated with larger gastric residual volumes or diarrhea.
74 .40 +/- 1.16 muL) syringes showed the lowest residual volume (P < 0.001) in comparison with the other
75 ume in one second (FEV1) (P=0.004), a higher residual volume (P=0.007), a lower ratio of FEV1 to forc
76 female, 27 male; mean age, 66 +/- 8 yr; mean residual volume percent predicted, 255 +/- 47%) were inc
77 l lung capacity % predicted (p=0.05), higher residual volume % predicted (p=0.04), lower maximal card
78 an +/- SD]; FEV1, % predicted, 29.3 +/- 6.5; residual volume, % predicted, 275.4 +/- 59.4) were alloc
79                                          The residual volume proportion and residual volume average K
80 e score, maximum urinary flow rate, postvoid residual volume, prostate-specific antigen (PSA), and pr
81 ary bother, nocturia, peak uroflow, postvoid residual volume, prostate-specific antigen level, partic
82 tional simulations also demonstrated a lower residual volume rate in the SOK group than in the KP gro
83 /- 1.3 versus 7.65 +/- 2.1 L, p < 0.001) and residual volume (RV) (3.7 +/- 1.2 versus 4.9 +/- 1.1 L,
84   CT images at total lung capacity (TLC) and residual volume (RV) of 541 former smokers and 59 health
85 ity (FVC), pre- and postbronchodilator FEV1, residual volume (RV), and total lung capacity (TLC) were
86                Hyperinflation was present at residual volume (RV), FRC, and TLC in all subjects.
87 expression on patrolling monocytes predicted residual volume (RV), RV/TLC ratio, and FRC, after adjus
88 ollowing the surgically induced reduction in residual volume (RV).
89 al capacity (FRC) and almost all the lung at residual volume (RV).
90 significant and similar decreases in TLC and residual volume (RV).
91 as inflated to 80% TLC, and then deflated to residual volume (RV).
92            After 3-month ICS/LABA treatment, residual volume (RV)/total lung capacity (TLC)% predicte
93  treatment group (n = 50) spirometric, Feno, residual volume (RV)/total lung capacity (TLC), AHR, and
94                                     Elevated residual volumes (RV), considered a marker for the risk
95 5-T whole-body MR unit at four lung volumes (residual volume [ RV residual volume ], functional resid
96 1.0 +/- 4.5% predicted), and hyperinflation (residual volume [RV] 341.8 +/- 75.8% predicted).
97 ents who had severe hyperinflation (ratio of residual volume [RV] to total lung capacity of >/=0.65).
98 g (FEV1, 0.73 +/- 0.2 L; TLC, 7.3 +/- 1.6 L; residual volume [RV], 4.8 +/- 1.4 L), and moderate resti
99                                   A postvoid residual volume should be measured prior to commencing a
100 ; 95% confidence interval [CI]: 0.21, 0.91), residual volume (static hyperinflation, r = -0.8; 95% CI
101 cantly reduced bladder capacity and postvoid residual volume than diabetic rats injected with the con
102 ng capacity (TLC) (P = 0.02) and % predicted residual volume/TLC (P = 0.05).
103            Sixty-nine bottles had sufficient residual volume to conduct HPLC analysis.
104 ith a corresponding increase in the ratio of residual volume to micturition volume.
105 rway obstruction as assessed by the ratio of residual volume to total lung capacity (RV/ TLC) (r = 0.
106 = 0.48, P <.005), percent predicted ratio of residual volume to total lung capacity (RV/TLC%) (r = -0
107 ion common to these diseases is the ratio of residual volume to total lung capacity (RV/TLC).
108 C, inspiratory lung resistance, and ratio of residual volume to total lung capacity postalbuterol pre
109 (P=0.02) and with hyperinflation measured as residual volume to total lung capacity ratio (P=0.009).
110  by days 14 and 21 (P=.02); and the ratio of residual volume to total lung capacity, a measure of tho
111             Air trapping correlated with the residual volume-to-total lung capacity ratio (rho = 0.6,
112 arbon monoxide (beta = 0.60, P = .0008), and residual volume/total lung capacity (beta = -0.26, P = .
113                   HI was defined as either a residual volume/total lung capacity (RV/TLC) above the u
114                                              Residual volume/total lung capacity (RV/TLC) ratio decre
115 junction line length and tracheal index with residual volume/total lung capacity (RV/TLC).
116 % predicted VCmax (P = 0.05), and decreasing residual volume/total lung capacity (TLC) (P = 0.02) and
117 VRS led to a relative reduction in mean (SD) residual volume/total lung capacity of -12% (12%) and an
118 w limitation (FEV1/forced vital capacity and residual volume/total lung capacity ratios) and greater
119                Hyperinflation was defined as residual volume/total lung capacity.
120 6+/-712 ml above the baseline value, and the residual volume was 333+/-570 ml below the baseline valu
121                               An increase in residual volume was noted in one heterozygous family mem
122                                              Residual volume was unexpectedly reduced by 18% in micro
123                  To obtain the delivered and residual volumes, we weighed the syringe-needle setups w
124 analyzing a solvent aliquot evaporated to 1% residual volume, while the other four nulls were properl
125  trials demonstrated an increase in postvoid residual volume with anticholinergic therapy.
126  index and a 429 ml (P < 0.001) reduction in residual volume with fluticasone furoate/vilanterol vers

 
Page Top